| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases
|
Veronesi, U.
|
|
|
18 |
3 |
p. 473-478
|
artikel
|
| 2 |
A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours
|
Scott, L.
|
|
|
18 |
3 |
p. 569-575
|
artikel
|
| 3 |
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients
|
Santini, D.
|
|
|
18 |
3 |
p. 576-580
|
artikel
|
| 4 |
Are sales representatives and the sale strategies of pharmaceutical companies getting too aggressive towards physicians?
|
Bernardi, D.
|
|
|
18 |
3 |
p. 607
|
artikel
|
| 5 |
Artificial intelligences in urological practice: the key to success?
|
Cai, T.
|
|
|
18 |
3 |
p. 604-605
|
artikel
|
| 6 |
Assessment of renal toxicity and osteonecrosis of the jaws in patients receiving zoledronic acid for bone metastasis
|
Aguiar Bujanda, D.
|
|
|
18 |
3 |
p. 556-560
|
artikel
|
| 7 |
Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients
|
Oskay-Özcelik, G.
|
|
|
18 |
3 |
p. 479-484
|
artikel
|
| 8 |
Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration
|
Humber, C.E.
|
|
|
18 |
3 |
p. 409-420
|
artikel
|
| 9 |
clairvoyance or reliable prediction of the future?
|
van Zandwijk, N.
|
|
|
18 |
3 |
p. 407-408
|
artikel
|
| 10 |
Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors
|
Sessa, C.
|
|
|
18 |
3 |
p. 561-568
|
artikel
|
| 11 |
Continuing declines in cancer mortality in the European Union
|
Levi, F.
|
|
|
18 |
3 |
p. 593-595
|
artikel
|
| 12 |
Correction to: Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression. Ann Oncol 2006; 17: 1625–1630
|
Soo, R.A.
|
|
|
18 |
3 |
p. 611
|
artikel
|
| 13 |
Cost-effectiveness of postremission intensive therapy in patients with acute leukemia
|
Yu, Y.-B.
|
|
|
18 |
3 |
p. 529-534
|
artikel
|
| 14 |
Does low-molecular-weight heparin influence cancer-related mortality?
|
Meyer, G.
|
|
|
18 |
3 |
p. 609-610
|
artikel
|
| 15 |
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy
|
Dziadziuszko, R.
|
|
|
18 |
3 |
p. 447-452
|
artikel
|
| 16 |
Estimates of the cancer incidence and mortality in Europe in 2006
|
Ferlay, J.
|
|
|
18 |
3 |
p. 581-592
|
artikel
|
| 17 |
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Entérologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study
|
Taïeb, J.
|
|
|
18 |
3 |
p. 498-503
|
artikel
|
| 18 |
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
|
Bellmunt, J.
|
|
|
18 |
3 |
p. 522-528
|
artikel
|
| 19 |
High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity
|
Fizazi, K.
|
|
|
18 |
3 |
p. 518-521
|
artikel
|
| 20 |
History of treated hypertension and diabetes mellitus and risk of renal cell cancer
|
Zucchetto, A.
|
|
|
18 |
3 |
p. 596-600
|
artikel
|
| 21 |
in this issue
|
|
|
|
18 |
3 |
p. 405
|
artikel
|
| 22 |
Lethal toxicity of uracil/tegafur in the treatment of sigmoid carcinoma
|
Bosch, T.M.
|
|
|
18 |
3 |
p. 607-608
|
artikel
|
| 23 |
Metastin (KISS-1) and metastin-coupled receptor (GPR54) expression in transitional cell carcinoma of the bladder
|
Nicolle, G.
|
|
|
18 |
3 |
p. 605-607
|
artikel
|
| 24 |
Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005
|
Bosetti, C.
|
|
|
18 |
3 |
p. 431-446
|
artikel
|
| 25 |
Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers
|
Alam, S.M.
|
|
|
18 |
3 |
p. 485-490
|
artikel
|
| 26 |
Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)
|
Pinto, C.
|
|
|
18 |
3 |
p. 510-517
|
artikel
|
| 27 |
Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients
|
Bossi, P.
|
|
|
18 |
3 |
p. 601-602
|
artikel
|
| 28 |
Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes
|
Song, K.W.
|
|
|
18 |
3 |
p. 535-540
|
artikel
|
| 29 |
Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer
|
Kwon, H.-C.
|
|
|
18 |
3 |
p. 504-509
|
artikel
|
| 30 |
Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study
|
Bidoli, P.
|
|
|
18 |
3 |
p. 461-467
|
artikel
|
| 31 |
RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer
|
Pijnenborg, J.M.A.
|
|
|
18 |
3 |
p. 491-497
|
artikel
|
| 32 |
Reversible posterior leukoencephalopathy syndrome after carboplatin therapy
|
Vieillot, S.
|
|
|
18 |
3 |
p. 608-609
|
artikel
|
| 33 |
Table of Contents
|
|
|
|
18 |
3 |
p. iv-vi
|
artikel
|
| 34 |
Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer
|
Cruz, J.J.
|
|
|
18 |
3 |
p. 421-430
|
artikel
|
| 35 |
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer
|
Weiss, G.J.
|
|
|
18 |
3 |
p. 453-460
|
artikel
|
| 36 |
The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma
|
Arkenau, H.-T.
|
|
|
18 |
3 |
p. 541-545
|
artikel
|
| 37 |
Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis
|
Fagnani, D.
|
|
|
18 |
3 |
p. 551-555
|
artikel
|
| 38 |
Thymoma and progressive T-cell lymphocytosis
|
Morales, M.
|
|
|
18 |
3 |
p. 603-604
|
artikel
|
| 39 |
Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies
|
Mouridsen, H.T.
|
|
|
18 |
3 |
p. 546-550
|
artikel
|
| 40 |
When can a second conservative approach be considered for ipsilateral breast tumour recurrence?
|
Gentilini, O.
|
|
|
18 |
3 |
p. 468-472
|
artikel
|
Tijdschrift beschrijving